Oglesby A, Sherif B, Odom D, Leahy M, Qian Y. Time and costs associated with preparing and administering zoledronic acid in patients with breast or prostate cancer and metastatic bone disease. Community Oncol. 2009 Nov 1;6(11):494-502.
Ehrenstein V, Rothman KJ, Pedersen L, Hatch EE, Sorensen HT. Pregnancy-associated hypertensive disorders and adult cognitive function among Danish conscripts. Am J Epidemiol. 2009 Oct 15;170(8):1025-31.
Earnshaw S, McDade CL, Black L, Kattan M. Cost-effectiveness of chemoprevention with dutasteride based on results from the REDUCE clinical trial. Poster presented at the 2009 ISPOR 12th Annual European Congress; October 28, 2009. [abstract] Value Health. 2009 Oct; 12(7):A371.
Starke JR, Mucci L, Rothman KJ, Adami HO. Screening for prostate cancer remains controversial. BMJ. 2009 Sep 24;339(7724):b3601.
Nørgaard M, Wogelius P, Pedersen L, Rothman KJ, Sørensen HT. Maternal use of oral contraceptives during early pregnancy and risk of hypospadias in male offspring. Urology. 2009 Sep;74(3):583-7.
Poulos C, Levin C, Hoang V, Yang J, Nguyen D. Mothers' and fathers' private demand for HPV vaccines in Viet Nam. Poster presented at the 7th World Congress on Health Economics: Harmonizing Health and Economics; July 2009.
Chen L, Candrilli SD. Age-segmented rates of treatment, goal attainment, comorbidities and lifestyle risks among men diagnosed with hypertension and dyslipidemia in the United States. Poster presented at the 2009 Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke Conference; April 2009.